MicroMed VAD Approval May Coincide With Inpatient Reimbursement Update
This article was originally published in The Gray Sheet
Executive Summary
A new diagnosis related group, DRG 525 (heart assist system implants), could improve Medicare reimbursement for Thoratec's HeartMate-VE left-ventricular assist device as an alternative to transplant, pending FDA approval of the expanded indication
You may also be interested in...
WorldHeart HeartSaver R&D Consolidation: 25% Personnel Cut Planned
WorldHeart's plan to merge the HeartSaverVAD and HeartSaverVADII development programs will save $10 mil. per year and help the firm reach profitability by 2004, the left-ventricular assist device maker predicts
WorldHeart HeartSaver R&D Consolidation: 25% Personnel Cut Planned
WorldHeart's plan to merge the HeartSaverVAD and HeartSaverVADII development programs will save $10 mil. per year and help the firm reach profitability by 2004, the left-ventricular assist device maker predicts
WorldHeart LVAD Destination Therapy In Line At FDA Behind Thoratec
WorldHeart will submit a PMA supplement in the third quarter seeking a destination therapy indication for its Novacor left-ventricular assist device